Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Rekha Vij

Concepts (221)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Diseases, Interstitial
18
2021
216
3.880
Why?
Idiopathic Pulmonary Fibrosis
15
2021
144
2.330
Why?
Idiopathic Interstitial Pneumonias
4
2018
30
1.260
Why?
Connective Tissue Diseases
6
2018
70
1.170
Why?
Autoimmunity
4
2018
163
0.960
Why?
Tomography, X-Ray Computed
12
2021
2569
0.880
Why?
Arthritis, Rheumatoid
3
2021
156
0.860
Why?
Autoimmune Diseases
4
2017
233
0.810
Why?
Hypertension, Pulmonary
4
2018
340
0.710
Why?
Sarcoidosis, Pulmonary
1
2015
17
0.620
Why?
Epoprostenol
1
2015
54
0.610
Why?
Vascular Resistance
1
2015
106
0.610
Why?
Multiple Myeloma
5
2017
285
0.590
Why?
Pulmonary Wedge Pressure
1
2015
109
0.590
Why?
Carrier Proteins
1
2018
685
0.570
Why?
Vasodilator Agents
1
2015
180
0.560
Why?
Alveolitis, Extrinsic Allergic
3
2017
30
0.480
Why?
Immunosuppressive Agents
6
2019
1026
0.480
Why?
Thalassemia
1
2010
17
0.440
Why?
Aged
31
2021
18500
0.430
Why?
Prevalence
8
2021
1263
0.420
Why?
Lung
5
2021
1059
0.410
Why?
Retrospective Studies
20
2021
7634
0.400
Why?
Pulmonary Fibrosis
5
2019
119
0.400
Why?
Middle Aged
34
2021
25587
0.400
Why?
Disease Progression
6
2021
1470
0.390
Why?
Male
38
2021
41881
0.390
Why?
Anemia, Sickle Cell
1
2010
129
0.380
Why?
Female
40
2021
44762
0.380
Why?
Humans
49
2021
83350
0.360
Why?
Lung Diseases
1
2010
268
0.360
Why?
Survival Analysis
10
2019
1583
0.360
Why?
Hematopoietic Stem Cell Transplantation
7
2017
812
0.360
Why?
Predictive Value of Tests
4
2021
1756
0.350
Why?
Mucin-5B
2
2019
13
0.350
Why?
Respiratory Function Tests
3
2018
147
0.330
Why?
Acetylcysteine
2
2018
76
0.320
Why?
Radiography, Thoracic
2
2018
322
0.300
Why?
Prognosis
11
2021
3704
0.300
Why?
Cohort Studies
11
2021
2708
0.270
Why?
Survival Rate
9
2019
1919
0.270
Why?
Rheumatoid Factor
1
2021
26
0.240
Why?
Mediastinal Diseases
1
2021
24
0.230
Why?
Antibodies, Antinuclear
2
2018
88
0.230
Why?
Inhalation Exposure
1
2021
28
0.220
Why?
Occupational Health
1
2021
34
0.220
Why?
Hematology
1
2020
31
0.210
Why?
Telomerase
1
2020
56
0.210
Why?
Stem Cell Transplantation
2
2015
190
0.210
Why?
Occupational Exposure
1
2021
75
0.210
Why?
Proportional Hazards Models
5
2018
870
0.200
Why?
Killer Cells, Natural
1
2021
304
0.190
Why?
Mediastinum
1
2019
50
0.190
Why?
Continuous Positive Airway Pressure
1
2020
87
0.190
Why?
Genetic Predisposition to Disease
3
2019
2226
0.180
Why?
Gene Expression Profiling
2
2015
1367
0.180
Why?
Patient Compliance
1
2020
247
0.180
Why?
Free Radical Scavengers
1
2018
64
0.180
Why?
Myositis
1
2017
17
0.180
Why?
DNA
2
2014
1305
0.170
Why?
Pathology, Clinical
1
2017
37
0.170
Why?
Transcriptome
1
2021
513
0.170
Why?
Prednisone
1
2017
264
0.170
Why?
Neoplasm Recurrence, Local
2
2017
1185
0.160
Why?
Adult
19
2021
25984
0.160
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
2
2007
108
0.160
Why?
Pulmonary Alveoli
1
2016
84
0.160
Why?
Sleep Apnea, Obstructive
1
2020
264
0.160
Why?
Leukocytes, Mononuclear
2
2015
198
0.160
Why?
Azathioprine
1
2016
126
0.160
Why?
Adjuvants, Immunologic
1
2017
165
0.160
Why?
Graft vs Host Disease
3
2005
336
0.160
Why?
Tacrolimus
1
2017
384
0.150
Why?
Hospitalization
2
2018
766
0.150
Why?
Lymph Nodes
1
2019
530
0.140
Why?
Anti-Inflammatory Agents
1
2017
343
0.140
Why?
Polymorphism, Genetic
1
2019
821
0.140
Why?
Bone Resorption
1
2014
49
0.140
Why?
Dose-Response Relationship, Drug
2
2017
2100
0.140
Why?
Diphosphonates
1
2014
39
0.140
Why?
Telomere Shortening
1
2014
24
0.140
Why?
Bone Density Conservation Agents
1
2014
48
0.140
Why?
Registries
4
2021
662
0.140
Why?
Administration, Oral
1
2015
726
0.130
Why?
Lymphoma, Non-Hodgkin
2
2007
265
0.130
Why?
Polymyositis
1
2013
7
0.130
Why?
Dermatomyositis
1
2013
19
0.130
Why?
Imidazoles
1
2014
168
0.130
Why?
Immunity, Innate
1
2017
428
0.130
Why?
Intracellular Signaling Peptides and Proteins
1
2015
384
0.130
Why?
Sjogren's Syndrome
1
2013
29
0.130
Why?
Scleroderma, Systemic
1
2013
40
0.130
Why?
Time Factors
3
2021
5496
0.130
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2000
2313
0.120
Why?
Drug Therapy, Combination
1
2015
991
0.120
Why?
Diagnosis, Differential
4
2018
1605
0.120
Why?
Acute Disease
3
2010
862
0.120
Why?
Oligopeptides
1
2013
186
0.120
Why?
Dyspnea
1
2012
80
0.120
Why?
Follow-Up Studies
2
2015
3877
0.120
Why?
Chromosome Aberrations
1
2013
399
0.110
Why?
Phenotype
4
2020
2293
0.110
Why?
Severity of Illness Index
2
2020
1778
0.110
Why?
Biopsy
3
2021
1180
0.100
Why?
Treatment Outcome
8
2019
7895
0.100
Why?
Models, Genetic
1
2015
923
0.100
Why?
Antihypertensive Agents
1
2015
573
0.100
Why?
Multivariate Analysis
3
2018
1011
0.100
Why?
Risk Assessment
4
2021
2281
0.100
Why?
Practice Guidelines as Topic
1
2018
1086
0.100
Why?
African Americans
1
2018
1167
0.100
Why?
Breast Neoplasms
2
2000
2778
0.100
Why?
United States
5
2021
6306
0.090
Why?
Mutation
3
2020
3861
0.090
Why?
Sensitivity and Specificity
3
2018
2079
0.090
Why?
Prospective Studies
2
2021
4081
0.090
Why?
Platelet Transfusion
1
2007
15
0.090
Why?
Longitudinal Studies
3
2021
984
0.090
Why?
Lymphocyte Count
1
2007
98
0.090
Why?
Cause of Death
2
2019
273
0.090
Why?
In Situ Hybridization, Fluorescence
2
2020
359
0.080
Why?
Propensity Score
2
2018
131
0.080
Why?
Hematopoietic Stem Cell Mobilization
1
2005
50
0.080
Why?
Genetic Variation
1
2013
1361
0.070
Why?
Reproducibility of Results
3
2018
2674
0.070
Why?
Disease-Free Survival
3
2017
1196
0.070
Why?
Genome-Wide Association Study
1
2013
1530
0.070
Why?
Peripheral Blood Stem Cell Transplantation
1
2005
69
0.070
Why?
Lymphocytes
1
2007
477
0.070
Why?
Tachycardia, Supraventricular
1
2004
21
0.070
Why?
Cluster Analysis
2
2017
373
0.070
Why?
Kaplan-Meier Estimate
2
2018
898
0.070
Why?
Recurrence
2
2017
1196
0.070
Why?
Chronic Disease
2
2017
966
0.070
Why?
Antineoplastic Agents, Hormonal
2
2000
153
0.060
Why?
Asthma
1
2010
888
0.060
Why?
Risk
3
2015
700
0.060
Why?
Transplantation, Autologous
2
2017
331
0.060
Why?
Oligonucleotide Array Sequence Analysis
2
2015
702
0.060
Why?
Antilymphocyte Serum
1
2001
86
0.060
Why?
Antineoplastic Agents
1
2013
2362
0.060
Why?
Life Tables
1
2000
51
0.060
Why?
Neoplasms, Hormone-Dependent
1
2000
39
0.050
Why?
Genotype
2
2019
1856
0.050
Why?
Leukemia
2
2001
300
0.050
Why?
Aged, 80 and over
3
2017
6576
0.050
Why?
Chicago
2
2017
1452
0.050
Why?
Biology
1
2020
41
0.050
Why?
Steroids
1
2001
175
0.050
Why?
Telomere
1
2020
96
0.050
Why?
Radiotherapy, Adjuvant
1
2000
307
0.050
Why?
Combined Modality Therapy
2
2000
1682
0.050
Why?
Chemotherapy, Adjuvant
1
2000
467
0.050
Why?
Texas
2
2014
83
0.050
Why?
Remission Induction
1
2000
715
0.050
Why?
Receptors, Estrogen
1
2000
382
0.050
Why?
Mastectomy
1
2000
233
0.050
Why?
Bronchoalveolar Lavage
1
2017
25
0.040
Why?
Microarray Analysis
1
2017
103
0.040
Why?
Immunoglobulin A
1
2017
98
0.040
Why?
Pulmonary Diffusing Capacity
1
2016
24
0.040
Why?
Treatment Failure
1
2017
303
0.040
Why?
Neoplasm Proteins
1
2000
547
0.040
Why?
Vital Capacity
1
2016
60
0.040
Why?
Mycophenolic Acid
1
2016
84
0.040
Why?
Fibrosis
1
2017
189
0.040
Why?
Molecular Targeted Therapy
1
2019
273
0.040
Why?
Cross-Sectional Studies
1
2021
1433
0.040
Why?
Antigens, CD34
2
2007
159
0.040
Why?
Statistics as Topic
1
2017
242
0.040
Why?
Lung Transplantation
1
2018
237
0.040
Why?
Cross-Over Studies
1
2016
414
0.040
Why?
Down-Regulation
1
2017
524
0.040
Why?
Pulmonary Artery
1
2017
297
0.040
Why?
Transplantation, Homologous
3
2005
1021
0.040
Why?
Flow Cytometry
1
2017
725
0.040
Why?
Promoter Regions, Genetic
1
2019
942
0.040
Why?
Observer Variation
1
2017
621
0.040
Why?
Analysis of Variance
2
2012
962
0.040
Why?
San Francisco
1
2014
20
0.040
Why?
Antigens
1
2016
270
0.040
Why?
Risk Factors
2
2021
5412
0.040
Why?
Logistic Models
1
2018
1157
0.030
Why?
Veterans
1
2014
55
0.030
Why?
Regression Analysis
1
2015
625
0.030
Why?
Comparative Effectiveness Research
1
2014
48
0.030
Why?
Radiographic Image Enhancement
1
2016
466
0.030
Why?
Environmental Exposure
1
2016
270
0.030
Why?
Evidence-Based Medicine
1
2016
453
0.030
Why?
Leukocytes
1
2014
195
0.030
Why?
Signal Transduction
2
2015
3300
0.030
Why?
Comorbidity
1
2017
937
0.030
Why?
Gene Expression
1
2017
1331
0.030
Why?
Linkage Disequilibrium
1
2013
482
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
923
0.030
Why?
Self Report
1
2012
262
0.030
Why?
Genomics
1
2015
647
0.030
Why?
Neutropenia
1
2007
223
0.020
Why?
Polymorphism, Single Nucleotide
1
2015
2338
0.020
Why?
Drug Evaluation
1
2005
151
0.020
Why?
Histocompatibility Testing
1
2005
157
0.020
Why?
Cell Count
1
2005
212
0.020
Why?
Antigens, CD
1
2007
484
0.020
Why?
Siblings
1
2005
112
0.020
Why?
Young Adult
1
2017
5968
0.020
Why?
Granulocyte Colony-Stimulating Factor
1
2005
167
0.020
Why?
Adolescent
3
2005
9135
0.020
Why?
Neoplasm Staging
1
2007
1924
0.010
Why?
Graft Survival
1
2005
884
0.010
Why?
Actuarial Analysis
1
2001
69
0.010
Why?
Drug Resistance
1
2001
266
0.010
Why?
Mastectomy, Modified Radical
1
1999
7
0.010
Why?
Oregon
1
1999
25
0.010
Why?
Incidence
1
2004
1638
0.010
Why?
Washington
1
1999
42
0.010
Why?
Tamoxifen
1
1999
165
0.010
Why?
Neoadjuvant Therapy
1
1999
272
0.010
Why?
Radiotherapy
1
1999
338
0.010
Why?
Infant
1
2001
3099
0.010
Why?
Child, Preschool
1
2001
3756
0.010
Why?
Child
1
2001
6759
0.010
Why?
Vij's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_